Asianet News English

Irrfan Khan no more: Filmmaker Shoojit Sircar confirms news on Twitter

 Irrfan Khan was admitted to Mumbai’s Kokilaben Dhirubhai Ambani Hospital on Tuesday. He was kept under observation for infection. 

Irrfan Khan no more: Filmmaker Shoojit Sircar confirms news on Twitter
BANGALORE, First Published Apr 29, 2020, 12:14 PM IST
  • Facebook
  • Twitter
  • Whatsapp

Noted actor Irrfan Khan has been admitted in the ICU of Kokilaben Hospital in Mumbai because of a colon infection, his family said on Tuesday.

He was kept under observation for colon infection. The actor in 2018 had announced that he’d been diagnosed with a neuroendocrine tumour.

The news of his death was shared on Twitter by filmmaker Shoojit Sircar. “My dear friend Irfaan. You fought and fought and fought. I will always be proud of you.. we shall meet again.. condolences to Sutapa and Babil.. you too fought, Sutapa you gave everything possible in this fight. Peace and Om shanti. Irfaan Khan salute,” he wrote.

A few week ago, the actor had shared an empowering video message for his fans, stating that the only choice he had was to remain positive. “One doesn’t have any other choice but to remain positive. Whether you are able to make lemonade in such situations is entirely up to you. We’ve made this film with the same sort of positivity. I hope this film is able to make you laugh and cry in equal measure.”

The Piku actor lost his 95-year-old mother Saeeda Begum in Jaipur just three days ago and could not attend the funeral because of the nationwide lockdown to contain the spread of coronavirus.

In early 2018, Irrfan had revealed his neuroendocrine tumour diagnosis. The actor stayed away from the public eye as he underwent treatment in the UK.

After his return in 2019, he shot for Angrezi Medium, the sequel to his 2017 hit Hindi Medium.

However, his health condition prevented him from promoting the movie, which hit the theatres in March just before the lockdown that began on March 25.

(Inputs from PTI)

Follow Us:
Download App:
  • android
  • ios